drugset / Trial / NCT02068053
Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020
NaSingle-groupOpen-label
Summary
The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and extent of elimination, as well as safety and tolerability of a single oral solution dose of \[14C\] Bristol-Myers Squibb (BMS)-986020 in healthy male subjects.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986020 | Small molecule | 600 mg | Oral |